Work

A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.5553

Authors: Roisin Eilish O'Cearbhaill, Sacha Gnjatic, Carol Aghajanian, Alexia Iasonos, Jason A. Konner, Nicolle Losada, Debra Sarasohn, Teresa Rasalan, William P. Tew, Dmitriy Zamarin, Phillip Wong, Paul Sabbatini

Institutions: Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890127917

Cites:

Cited by: 6

Related to: 10